observ
experiment
studi
continu
support
associ
infect
infectionstimul
inflamm
develop
cardiovascular
diseas
cvd
includ
atherosclerosi
thrombosi
microvesicl
mv
heterogen
popul
seal
membranederiv
vesicl
shed
circul
activ
mammalian
cell
andor
pathogen
microb
may
repres
interfac
bacterialmicrobi
infect
increas
risk
cvd
review
evalu
mv
act
modul
intersect
immunolog
inflammatori
respons
infect
particular
attent
progress
cvd
infectionrel
stimuli
provok
releas
mv
blood
vascular
cell
mv
express
phosphatidylserin
ps
procoagul
factor
surfac
initi
amplifi
blood
coagul
addit
mv
mediat
cellcel
adhes
may
stimul
product
proinflammatori
cytokin
vascular
cell
turn
aggrav
progress
cvd
propag
atherothrombosi
mv
transfer
membran
receptor
rna
protein
among
cell
present
autoantigen
cell
origin
proxim
remot
target
cell
mv
harbor
cell
surfac
protein
contain
cytoplasm
compon
parent
cell
mediat
biolog
messag
play
pivot
role
crossroad
infectionstimul
inflamm
cardiovascular
diseas
chronic
acut
infect
especi
provok
gramneg
bacteria
increas
risk
cardiovascular
event
includ
instabl
atherosclerot
plaqu
format
microvascular
thrombi
increas
risk
thrombosi
seem
specif
one
type
infect
rather
seem
univers
potenti
consequ
infect
regardless
organ
system
affect
dental
infect
includ
periodont
infect
urinari
tract
upper
airway
system
sepsi
addit
exposur
infect
subsequ
inflammatori
respons
may
contribut
increas
incid
venou
thromboembol
hospit
addit
risk
thrombosi
gramneg
bacteria
exampl
chlamydia
pneumonia
c
pneumonia
caus
upper
respiratori
tract
infect
may
exacerb
coronari
arteri
diseas
cad
c
pneumonia
cultur
atherosclerot
plaqu
also
found
monocyt
macrophag
foam
cell
c
pneumonia
seem
ubiquit
popul
cad
contribut
pathobiolog
atherosclerot
plaqu
caus
inflamm
endotheli
dysfunct
microb
may
also
particip
develop
vascular
diseas
process
differ
microb
includ
staphylococcu
streptococcu
escherichia
coli
propionibacterium
acn
cultur
calcif
aortic
aneurysm
howev
mechan
microb
byproduct
initi
atherosclerot
injuri
facilit
progress
mere
colon
preexist
atheroma
modifi
diseas
progress
remain
controversi
one
mechan
emerg
link
infectionstimul
inflamm
alter
thrombot
potenti
blood
atherogen
process
infect
increas
product
activ
cell
membranederiv
proinflammatori
procoagul
microvesicl
mv
invad
microb
host
cell
activ
host
cellular
solubl
compon
cardiovascular
system
review
focu
first
gener
mv
infect
focu
direct
indirect
impact
mv
onset
progress
cvd
understand
infect
contribut
product
propag
mv
may
suggest
possibl
new
earli
diagnost
prognost
test
therapeut
target
prevent
treatment
reduc
progress
cvd
mv
heterogen
popul
activ
cell
membranederiv
seal
vesicl
rang
nm
shed
cell
surfac
respons
activ
apoptosi
term
microvesicl
microparticl
use
interchang
literatur
distinct
warrant
microparticl
microvesicl
may
overlap
size
distinct
doubl
membran
border
distinguish
mv
similar
size
microparticl
present
blood
includ
lipoprotein
protein
aggreg
proteinminer
aggreg
literatur
confus
term
ectosom
refer
membran
releas
vesicl
rightsideout
orient
vesicl
cytoplasm
content
mv
ectosom
seal
membran
vesicl
bear
antigen
cellular
origin
also
may
retain
protein
receptor
function
properti
parent
cell
thu
facilit
transcellular
commun
throughout
circul
deliv
bioactiv
molecul
even
genet
inform
come
contact
bind
cell
circul
blood
vessel
elev
level
circul
platelet
monocyteor
endothelialderiv
mv
associ
inflamm
cvd
mammalian
cell
gramneg
bacteria
microbi
pathogen
releas
mv
tabl
thu
infecti
agent
could
promot
format
mv
host
cell
convers
hostcellderiv
mv
could
provid
feedback
loop
either
exacerb
reduc
infect
inflamm
vascular
dysfunct
thrombot
process
site
distant
site
infect
mv
releas
physiolog
process
certain
type
cell
patholog
process
everi
type
mammalian
cell
exampl
plateletderiv
mv
observ
blood
healthi
human
mice
releas
follow
activ
platelet
varieti
stimuli
includ
adrenalin
adp
thrombin
collagen
ca
ionophor
complement
shear
stress
gener
format
mv
may
begin
within
minut
addit
agonist
rise
intracellular
calcium
platelet
inhibit
calcium
chelat
edta
egta
commonli
use
anticoagul
increas
cytosol
calcium
initi
kinas
mediat
reorgan
cytoskeleton
includ
myosin
lightchain
kinas
rhoassoci
kinas
proteas
like
calpain
howev
format
mv
uniform
process
releas
mv
differ
quantit
phenotyp
among
stimuli
exampl
endotheli
cell
releas
phenotyp
differ
mv
follow
exposur
proinflammatori
cytokin
tumor
necrosi
factor
initi
receptor
mediat
intracellular
signal
compar
exposur
media
strip
growth
factor
induc
apoptosi
endotheli
cellderiv
mv
gener
plasminogen
activ
inhibitor
produc
overlap
distinct
protein
composit
protein
distinct
exclus
relat
one
stimulu
earli
studi
analyz
purifi
mv
sdspage
reveal
pattern
limit
complex
howev
proteom
analysi
composit
mv
cem
tlymphocyt
cell
follow
stimul
phytohemagglutinin
h
actinomycin
h
support
idea
spectrum
protein
found
mv
influenc
part
type
stimulu
stimul
format
confoc
electron
microscop
imag
mv
format
provid
evid
select
arrang
sort
certain
protein
thu
transloc
cellular
molecul
mv
might
random
addit
work
need
fulli
appreci
differenti
signal
system
induc
variou
stimuli
determin
phenotyp
assess
mv
might
provid
use
inform
reflect
natur
cell
activ
injuri
diagnost
prognost
tool
treatment
option
upon
releas
mv
transport
biolog
activ
content
includ
lipid
protein
rna
cell
surfac
receptor
among
cell
specif
surfac
receptor
cellular
marker
use
identifi
origin
physiolog
statu
parent
cell
tabl
identifi
cellular
origin
establish
refer
rang
blood
born
mv
healthi
individu
possibl
understand
subpopul
may
contribut
specif
pathogen
process
bacteri
deriv
mv
made
outer
membran
engulf
periplasm
compon
serv
deliveri
system
genet
materi
protein
lipopolysaccharid
lp
promot
adher
bacterium
infect
host
cell
bacteria
mv
format
may
function
requir
bacteria
dna
packag
within
mv
protect
degrad
solubl
dnase
resist
antibiot
acquir
recipi
bacteria
integr
mv
parent
bacteria
speci
mv
releas
bacteria
may
contribut
infectioninduc
cardiovascular
diseas
like
coronari
arteri
diseas
sinc
virul
gene
lp
toxin
enzym
carri
mv
absorb
host
cell
mv
certain
speci
bacteria
like
p
gingivali
gramneg
bacteria
relat
chronic
periodont
activ
platelet
suggest
possibl
mechan
bacteriaderiv
mv
increas
risk
thrombosi
howev
even
though
bacterialderiv
mv
detect
infect
human
tissu
studi
evalu
bacteriaderiv
mv
lead
onset
progress
cvd
addit
inform
regard
product
bacteri
mv
obtain
normal
growth
bacteria
vitro
littl
known
mechan
underli
product
releas
bacteri
deriv
mv
stimuli
regul
product
composit
host
vivo
bacteria
activ
host
cell
mainli
bind
lp
major
pathogen
molecul
outer
membran
compon
gramneg
bacteria
tolllik
receptor
transmembran
glycoprotein
present
platelet
leukocyt
lymphocyt
endothelium
pig
infus
lp
mgkg
per
hr
mice
singl
intraperiton
inject
endotoxin
mgkg
increas
plateletderiv
mv
within
hour
respect
experi
like
provid
support
concept
infect
stimul
product
plateletderiv
mv
interpret
caution
measur
mv
singl
cellular
origin
provid
inform
gener
mv
cell
type
interact
among
mv
differ
cellular
origin
interact
mv
blood
cell
addit
depend
dose
lp
type
bacteri
infect
receptor
may
activ
therefor
complement
activ
cytokinemedi
mechan
vascular
cell
complic
unravel
mechan
lp
induc
product
host
mv
vitro
studi
use
identifi
effect
lp
blood
element
cell
vascular
wall
dilut
blood
prevent
cellcel
interact
addit
lp
ng
increas
number
tfbear
mv
mv
platelet
hour
incub
incub
human
monocyt
lp
hour
increas
total
number
mv
tfbear
mv
bear
phosphatidylserin
ps
adhes
molecul
mv
format
visual
fluoresc
microscopi
occur
leukocyt
endotheli
cell
incub
lp
min
thu
lp
stimul
mv
product
circul
blood
cell
cell
vascular
wall
unpublish
work
group
incub
whole
blood
lp
one
hour
dose
stimul
receptor
increas
total
number
mv
howev
leukocytederiv
mv
associ
platelet
subsequ
alter
reactiv
statu
platelet
figur
data
provid
evid
studi
mv
gener
one
cell
type
respons
lp
alter
reactiv
cell
type
within
circul
although
exist
data
provid
evid
lp
induc
mv
releas
isol
cell
cell
vitro
studi
need
understand
bacteri
protein
affect
mv
product
host
cell
vivo
particular
studi
need
determin
whether
lp
natur
compon
bacteria
content
bacteriaderiv
mv
affect
composit
infect
mammalian
cellderiv
mv
distinct
stimuli
mammalian
cell
releas
mv
respons
varieti
stimuli
associ
infect
mani
consid
convent
biomark
cvd
includ
inflammatori
cytokin
lipid
lipidperoxid
oxid
stress
apoptosi
stimuli
also
import
particip
defens
mechan
pathogenesi
infect
proinflammatori
agentsreleas
cytokin
provok
host
cell
invad
microorgan
may
turn
stimul
releas
mv
noninfect
cell
exampl
proinflammatori
cytokin
stimul
mv
product
endotheli
cell
monocyt
contain
tissu
factor
tf
high
procoagul
activ
activ
complement
compon
also
increas
releas
cellular
mv
endothelia
platelet
leukocytederiv
mv
significantli
increas
incub
fmlp
formylmethionylleucylphenylalanin
formyl
tripeptid
origin
isol
bacteri
filtrat
creactiv
protein
crp
promot
agglutin
bacteri
phagocytosi
acutephas
respons
protein
produc
liver
respons
infect
well
cytokin
crp
elev
individu
risk
recurr
myocardi
infarct
coronari
heart
diseas
stroke
may
predict
risk
futur
cardiovascular
event
howev
circul
crp
use
biomark
inflamm
specif
biomark
link
inflamm
acut
chronic
infect
cvd
oxid
stress
metabol
failureoxid
stress
character
disrupt
oxid
antioxid
system
within
cell
increas
infect
inflamm
immunolog
disord
reactiv
oxygen
speci
ro
damag
cellular
membran
structur
lead
releas
mv
oxid
stress
common
mechan
underli
cardiovascular
diseas
divers
therapeut
intervent
antioxid
imped
delay
onset
progress
cardiovascular
diseas
oxid
stress
marker
independ
increas
total
number
mv
mv
deriv
platelet
energet
failur
within
platelet
also
associ
increas
shed
thrombogen
mv
may
result
decreas
activ
enzym
mitochondri
electron
transport
chain
oxid
stress
also
caus
membran
phospholipid
rearrang
psbear
mv
shed
red
blood
cell
oxid
stress
endotheli
cell
increas
releas
mv
express
vascular
cell
adhes
endotheliumderiv
mv
releas
respons
oxid
stress
stimul
neutrophil
adhes
via
plateletactiv
factor
paf
receptor
howev
exact
mechan
oxid
stress
metabol
failur
lead
mv
releas
clear
chronic
treatment
antioxid
vitamin
c
carvedilol
decreas
circul
endotheli
mv
patient
heart
failur
exhibit
protect
effect
monocytederiv
mv
releas
apoptosi
induc
product
superoxid
anion
endotheli
cell
suggest
product
reactiv
oxygen
speci
result
stimulu
releas
mv
thu
repres
mechan
posit
feedback
cellular
injuri
reactiv
oxygen
speci
promot
procoagul
phenotyp
upregul
tf
express
activ
mv
apoptosisreleas
membran
bleb
mv
earli
featur
apoptosi
activ
variou
stressor
includ
bacteri
infect
cytokin
oxid
stress
releas
mv
may
protect
mechan
intracellular
stress
mv
contain
caspas
prevent
intracellular
accumul
enzym
could
allow
escap
apoptosi
thu
contribut
cell
surviv
mechan
lead
releas
mv
upon
apoptosi
partli
understood
loss
tumor
suppressor
gene
lead
increas
releas
tfbear
mv
mv
releas
cell
lack
releas
restor
transfect
function
result
implic
format
mv
oxid
stress
mv
releas
result
apoptosi
stimul
apoptosi
cell
plateletderiv
mv
contain
function
activ
induc
apoptosi
human
macrophag
cvd
particular
atherosclerosi
describ
inflammatori
diseas
howev
sourc
inflamm
usual
attribut
disrupt
metabol
relat
alter
lipid
metabol
preced
discuss
expand
view
includ
process
associ
infect
immun
inde
proinflammatori
cytokin
independ
risk
factor
cvd
person
chronic
infect
inflammatori
respons
increas
risk
atherosclerosi
number
type
mv
gener
infect
inflamm
thrombot
complic
suggest
mv
may
provid
interfac
infect
initi
amplif
cardiovascular
diseas
figur
format
mv
normal
phospholipid
asymmetri
membran
chang
expos
neg
charg
phospholipid
ps
inner
membran
leaflet
outer
membran
leaflet
thrombin
gener
capac
mv
proport
amount
ps
bear
surfac
number
mv
bear
ps
surfac
ps
offer
bind
site
coagul
factor
ii
va
xa
provid
platform
assembl
prothrombinas
complex
acceler
convers
prothrombin
thrombin
support
procoagul
phenotyp
mv
also
repres
reservoir
blood
born
tissu
factor
tf
activ
monocyt
polymorphonuclear
leukocyt
one
sourc
tfbear
mv
transfer
associ
platelet
trigger
propag
thrombosi
whether
platelet
produc
tf
controversi
may
three
distinct
sourc
platelet
tf
tf
taken
circul
monocytederiv
mv
tf
store
platelet
precursor
bone
megakaryocyt
taken
sourc
tf
synthes
express
plasma
membran
matur
platelet
rate
accumul
tf
plateletrich
thrombi
explain
recruit
leukocyt
onto
adher
platelet
one
mechan
explain
discrep
tfbear
mv
adher
platelet
bind
pselectin
glycoprotein
mv
pselectin
platelet
tissu
factor
exist
blood
inact
latent
activ
configur
tfbear
mv
circul
healthi
person
tf
activ
detect
addit
contribut
thrombin
format
fusion
tfbear
mv
activ
platelet
facilit
transfer
protein
lipid
platelet
membran
therefor
mv
modul
coagul
directli
initi
coagul
cascad
indirectli
via
activ
platelet
propos
tf
bear
mv
mainli
monocyt
lymphocyt
origin
contribut
thrombu
format
follow
ruptur
atherosclerot
plaqu
bind
activ
platelet
site
plaqu
ruptur
use
rat
aortic
ring
bioassay
mv
patient
acut
myocardi
infarct
initi
reduc
endotheliumdepend
relax
releas
nitric
oxid
compar
mv
patient
without
ischemia
reduct
endotheliumdepend
relax
consist
gener
vasomotor
dysfunct
observ
myocardi
infarct
potenti
would
contribut
increas
format
thrombu
decreas
tissu
perfus
endotheliumdepend
vasodilat
induc
acetylcholin
significantli
reduc
circul
mv
patient
metabol
syndrom
mv
deriv
diabet
patient
hivinfect
individu
also
reduc
acetylcholineinduc
attenu
shear
stressinduc
vasodilat
stimul
express
downregul
endotheli
nitric
oxid
synthas
eno
cultur
human
endotheli
cell
tlymphocytederiv
mv
may
increas
induc
nitric
oxid
synthas
ino
depend
transcript
mv
deriv
monocyt
lymphocyt
found
atherosclerot
plaqu
greater
concentr
deriv
platelet
condit
opposit
variou
number
mv
found
blood
may
reflect
activ
cell
migrat
vascular
lesion
leukocyteder
mv
may
associ
platelet
blood
regardless
cellular
origin
bacteri
host
mv
amplifi
progress
cvd
transfer
biolog
inform
cell
transfer
integrin
selectin
target
cell
mv
facilit
leukocyt
adhes
interact
vascular
endothelium
addit
plateletderiv
mv
enhanc
bind
neutrophil
neutrophil
flow
condit
via
pselectin
mv
neutrophil
monocyteendotheli
interact
stimul
plateletderiv
mv
upregul
express
cellular
adhes
molecul
endothelium
monocyt
process
relat
metabol
arachidon
acid
adhes
monocyt
neutrophil
endothelium
consid
crucial
step
earli
process
atherosclerot
lesion
like
plateletderiv
mv
rather
platelet
deliv
longrang
signal
cell
throughout
circul
sinc
aggreg
bind
properti
activ
platelet
make
difficult
travel
circulatori
system
consequ
mv
instead
intact
platelet
may
critic
enhanc
thrombosi
modul
innat
adapt
immun
respons
process
mv
attach
target
cell
complet
understood
addit
fusion
cell
membran
receptor
bind
describ
section
import
receptor
involv
may
differ
depend
upon
stimulu
mv
gener
mv
bear
result
stimul
endotheli
cell
bind
integrin
monocyt
increas
tf
gene
express
monocyt
induct
tfdepend
procoagul
activ
altern
fasfa
ligand
receptor
interact
might
import
bind
apoptot
mv
target
cell
discuss
lp
outer
membran
gramneg
bacteria
associ
bacteri
deriv
mv
activ
host
cell
part
signal
mechan
mutat
delet
decreas
risk
develop
atherosclerosi
increas
suscept
infect
genet
polymorph
monocyt
chemoattract
protein
receptor
chemokin
cc
motif
receptor
may
increas
suscept
chronic
stabl
angina
pectori
myocardi
infarct
proinflammatori
cytokin
stimul
mv
product
mv
turn
stimul
product
cytokin
thu
amplifi
signal
type
posit
feedback
exampl
stimul
leukocyt
endotoxin
complex
purifi
lp
induc
shed
mv
contain
paf
agonist
stimul
innat
immun
furthermor
prime
monocyt
lp
stimul
cell
atp
gener
mv
ps
posit
contain
bioactiv
converg
respons
initi
two
differ
agonist
suggest
gener
releas
mv
could
gener
pathway
secret
cytoplasm
protein
modul
immun
system
stimul
dendrit
cell
initi
acut
inflammatori
respons
addit
initi
immun
respons
mv
contribut
matur
immun
cell
mv
gener
thrombinactiv
platelet
carri
initi
matur
monocytederiv
dendrit
cell
turn
activ
tcell
platelet
mv
transfer
adapt
immun
bcell
compart
may
distant
site
platelet
activ
longrang
signal
result
product
antigenspecif
igg
mv
gener
endotheli
cell
respons
bacteri
infect
induc
matur
plasmacytoid
dendrit
cell
secret
inflammatori
cytokin
prolifer
allogen
tcell
respons
activ
either
platelet
tcell
deriv
mv
collect
respons
demonstr
coordin
interact
among
process
respond
infect
vascular
cell
activ
cytokin
implic
progress
cardiovascular
diseas
mv
deriv
invad
pathogen
host
cell
consid
vector
transcellular
exchang
signal
common
infect
gener
inflamm
procoagul
properti
blood
contribut
progress
cvd
virul
potenti
mv
deriv
pathogen
may
explain
part
consist
find
burden
infect
increas
develop
cvd
absenc
consist
identif
specif
pathogen
within
atherosclerot
lesion
literatur
abound
studi
gener
cellspecif
mv
character
variou
diseas
gener
methodolog
challeng
remain
develop
mv
diagnost
prognost
tool
challeng
includ
need
standard
method
blood
collect
process
includ
issu
relat
anticoagul
cellfre
plasma
prepar
blood
collect
may
affect
product
adhes
secret
mv
collect
sampl
second
challeng
better
understand
differ
stimuli
affect
product
content
mv
differenti
nonspecif
molecular
switch
common
gener
mv
variou
cell
type
third
challeng
defin
sex
age
modul
format
mv
variou
cell
type
might
influenc
thrombosi
immun
vascular
reactiv
exampl
estrogen
receptor
beta
knockout
femal
mice
show
higher
psexpress
plateletderiv
mv
plasma
thrombingener
capac
compar
wild
type
mice
addit
total
number
mv
deriv
platelet
monocyt
vascular
endothelium
posit
phosphatidylserin
tissu
factor
significantli
greater
p
newli
menopaus
women
circul
estrogen
compar
agematch
women
estrogen
result
infer
hormon
regul
mv
gener
thrombot
risk
sinc
incid
immunolog
disord
cardiovascular
risk
diverg
age
sex
understand
contribut
mv
associ
import
variabl
facilit
develop
effect
prevent
strategi
individu
atp
secret
respons
thrombin
uml
black
bar
platelet
associ
leukocytederiv
mv
gray
bar
whole
blood
mice
incub
lp
salin
control
p
vs
control
schemat
mv
gramneg
bacteria
may
interfac
host
cell
increas
progress
cardiovascular
diseas
tabl
comparison
pathogenderiv
mammalian
cellderiv
mv
